A detailed history of First Horizon Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 691,228 shares of PFE stock, worth $17.7 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
691,228
Previous 595,479 16.08%
Holding current value
$17.7 Million
Previous $16.7 Million 20.06%
% of portfolio
0.56%
Previous 0.51%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$27.7 - $31.39 $2.65 Million - $3.01 Million
95,749 Added 16.08%
691,228 $20 Million
Q2 2024

Jul 19, 2024

BUY
$25.26 - $29.6 $246,082 - $288,363
9,742 Added 1.66%
595,479 $16.7 Million
Q1 2024

Apr 26, 2024

BUY
$25.89 - $29.73 $2.27 Million - $2.6 Million
87,584 Added 17.58%
585,737 $16.3 Million
Q4 2023

Feb 06, 2024

BUY
$26.13 - $33.94 $148,731 - $193,186
5,692 Added 1.16%
498,153 $14.3 Million
Q3 2023

Oct 27, 2023

BUY
$32.09 - $37.51 $868,708 - $1.02 Million
27,071 Added 5.82%
492,461 $16.3 Million
Q2 2023

Aug 03, 2023

BUY
$36.12 - $41.79 $653,519 - $756,106
18,093 Added 4.04%
465,390 $17.1 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $587,698 - $765,097
14,920 Added 3.45%
447,297 $18.2 Million
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $235,010 - $306,780
5,629 Added 1.32%
432,377 $22.2 Million
Q3 2022

Nov 09, 2022

SELL
$43.76 - $53.42 $315,334 - $384,944
-7,206 Reduced 1.66%
426,748 $18.7 Million
Q2 2022

Aug 02, 2022

BUY
$46.53 - $55.17 $10.1 Million - $12 Million
216,699 Added 99.74%
433,954 $22.8 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $9.64 Million - $11.9 Million
-210,698 Reduced 49.23%
217,255 $11.2 Million
Q4 2021

Feb 09, 2022

BUY
$41.32 - $61.25 $546,043 - $809,418
13,215 Added 3.19%
427,953 $25.3 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $1.5 Million - $1.93 Million
38,317 Added 10.18%
414,738 $17.8 Million
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $3.05 Million - $3.91 Million
77,613 Added 25.97%
376,421 $16.2 Million
Q2 2021

Aug 09, 2021

SELL
$35.91 - $40.68 $260,275 - $294,848
-7,248 Reduced 2.37%
298,808 $11.7 Million
Q1 2021

May 11, 2021

BUY
$33.49 - $37.77 $2.11 Million - $2.38 Million
62,926 Added 25.88%
306,056 $11.1 Million
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $288,913 - $367,377
8,632 Added 3.68%
243,130 $8.95 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $232,219 - $272,446
7,314 Added 3.22%
234,498 $8.17 Million
Q2 2020

Jul 31, 2020

BUY
$30.12 - $36.54 $314,332 - $381,331
10,436 Added 4.81%
227,184 $7.05 Million
Q1 2020

May 05, 2020

BUY
$27.03 - $38.62 $593,984 - $848,674
21,975 Added 11.28%
216,748 $6.71 Million
Q4 2019

Jan 07, 2020

BUY
$32.92 - $37.36 $166,410 - $188,854
5,055 Added 2.66%
194,773 $7.24 Million
Q3 2019

Oct 23, 2019

SELL
$32.49 - $42.13 $188,864 - $244,901
-5,813 Reduced 2.97%
189,718 $6.47 Million
Q2 2019

Aug 05, 2019

BUY
$36.98 - $41.52 $536,986 - $602,911
14,521 Added 8.02%
195,531 $0
Q1 2019

Apr 26, 2019

BUY
$37.5 - $41.2 $428,362 - $470,627
11,423 Added 6.74%
181,010 $0
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $924,318 - $1.05 Million
-24,027 Reduced 12.41%
169,587 $7.02 Million
Q3 2018

Nov 05, 2018

BUY
$34.47 - $41.81 $4.76 Million - $5.77 Million
138,029 Added 248.32%
193,614 $0
Q3 2018

Nov 05, 2018

SELL
$34.47 - $41.81 $4.67 Million - $5.67 Million
-135,509 Reduced 70.91%
55,585 $0
Q2 2018

Aug 07, 2018

BUY
$32.98 - $35.16 $611,779 - $652,217
18,550 Added 10.75%
191,094 $0
Q1 2018

May 02, 2018

BUY
$31.91 - $37.02 $101,058 - $117,242
3,167 Added 1.87%
172,544 $0
Q4 2017

Jan 25, 2018

BUY
$33.26 - $35.29 $162,574 - $172,497
4,888 Added 2.97%
169,377 $0
Q3 2017

Nov 09, 2017

BUY
$31.0 - $34.15 $1.49 Million - $1.64 Million
48,125 Added 41.36%
164,489 $0
Q2 2017

Aug 14, 2017

BUY
N/A
116,364
116,364 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.